The influence of probiotics on immune system development during early childhood: a systematic review
DOI:
https://doi.org/10.18203/2349-3291.ijcp20263316Keywords:
Probiotics, Immune system, Early childhood, Gut microbiota, Immunological toleranceAbstract
Immune system development during early childhood is closely modulated by the colonization of the gut microbiota. Early interaction between commensal bacteria and the gut-associated lymphoid tissue (GALT) is essential for the maturation of both innate and adaptive immune responses, as well as for the establishment of immunological tolerance. Objective of the study was to analyze the current clinical evidence on the influence of probiotic supplementation on the development, maturation, and modulation of the immune system during early childhood, as well as its impact on preventing immune-based pathologies. Systematic review of scientific literature published between 2020 and 2026 in PubMed, Scopus, and Cochrane Library databases. Randomized controlled trials and cohort studies evaluating probiotic administration in infants and children (0-5 years) and measuring immunological biomarkers (e.g., secretory IgA, Th1/Th2/Th17 cytokine profiles) or immune-mediated clinical outcomes were included. The administration of specific strains, predominantly Lactobacillus rhamnosus GG, Bifidobacterium animalis subsp. lactis, and Lactobacillus reuteri, demonstrated a significant induction in intestinal secretory IgA (sIgA) synthesis and a favorable modulation of the Th1/Th2 ratio, thereby reducing pro-allergic polarization. Clinically, a consistent reduction in the incidence and severity of atopic dermatitis was observed in high-risk infants, alongside a significant decrease in the frequency and duration of upper respiratory and gastrointestinal infectious episodes. Probiotic supplementation during early childhood plays a key immunomodulatory role that supports the maturation of the infantile immune system. These findings support its use as a promising therapeutic and preventive strategy against highly prevalent allergic and infectious diseases, though greater standardization regarding strain specificity, dosage, and critical intervention windows is still required.
References
Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357(9262):1076-9.
Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73(2 Suppl):444S-50S.
Rautava S, Kalliomäki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol. 2002;109(1):119-21.
O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen L, et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and physiological correlates. Gastroenterology. 2005;128(3):541-51.
Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007;119(1):184-91.
Prescott SL, Björkstén B. Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol. 2007;120(2):255-62.
West CE, Hammarström ML, Hernell O. Probiotics in primary prevention of allergic disease and the development of mucosal immunity. Clin Exp Allergy. 2009;39(8):1276-86.
Rautava S, Salminen S, Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy–a randomised, double-blind, placebo-controlled study. Br J Nutr. 2009;101(11):1722-6.
Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics. 2010;126(3):e526-33.
Holscher HD, Czerkies LA, Cekola P, Litov R, Benbow M, Santema S, et al. Bifidobacterium lactis BB-12 enhances intestinal antibody response in healthy infants. J Pediatr Gastroenterol Nutr. 2012;55(3):273-7.
Berni Canani R, Nocerino R, Terrin G, Coruzzo A, Cosenza L, Leone L, et al. Effect of Lactobacillus GG supplementation on tolerance acquisition in infants with cow's milk allergy. J Allergy Clin Immunol. 2012;129(2):580-2.
Thomas DW, Greer FR; American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition. Probiotics and prebiotics in pediatrics. Pediatrics. 2010;126(6):1217-31.
Licciardi PV, Wong SS, Tang ML. The role of probiotics in early childhood immune development and allergy prevention. Curr Opin Allergy Clin Immunol. 2013;13(2):177-84.
Szajewska H, Urbańska O, Chmielewska A, Weizman Z, Shamir R. Meta-analysis: Lactobacillus reuteri strain DSM 17938 in the treatment of acute gastroenteritis in children. Aliment Pharmacol Ther. 2014;39(3):285-92.
Fiocchi A, Pawankar R, Cuello-Garcia C, Terracciano L, Bahna SL, Arshad SH, et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (WAO-McMaster): Probiotics. World Allergy Organ J. 2015;8(1):4.
Cuello-Garcia CA, Brożek JL, Fiocchi A, Pawankar R, Yepes-Nuñez JJ, Terracciano L, et al. Probiotics for the prevention of allergy: A systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2015;136(4):952-61.
Berni Canani R, Sangwan N, Stefka AT, Nocerino R, Paparo L, Aitoro R, et al. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J. 2016;10(3):742-50.
Azad MB, Konya T, Guttman DS, Field CJ, Sears MR, HayGlass KT, et al. Infant gut microbiota and the development of food allergy. J Allergy Clin Immunol. 2015;136(5):1257-65.
Bäckhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17(5):690-703.
Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352(6285):539-44.
Arrieta MC, Stiemsma LT, Amenyogbe N, Brown EM, Finlay B. The intestinal microbiome in early life: health and disease. Front Immunol. 2014;5:427.
Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30(6):492-506.
Ouowei M, Lamine M, Aris A. Probiotics and immunomodulation in pediatric populations: molecular targets on dendritic cells. Front Immunol. 2019;10:1425.
Plaza-Díaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of action of probiotics. Adv Nutr. 2019;10(suppl_1):S49-S66.
Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a narrative review. Front Immunol. 2021;12:605179.
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-14.
Szajewska H, Berni Canani R, Domellöf M, Guarino A, Hojsak I, Indrio F, et al. Probiotics for the management of pediatric gastrointestinal disorders: position paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications. J Pediatr Gastroenterol Nutr. 2023;76(2):232-47.
Quin C, Estaki M, Vollman DM, Barnett JA, Watson SK, Gibson DL. Probiotics, prebiotics, and intestinal barrier function in early life. Curr Allergy Asthma Rep. 2018;18(11):60.
Robertson RC, Manges AR, Finlay BB, Prendergast AJ. The microbiome and childhood undernutrition. Front Immunol. 2019;10:1800.
Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med. 2016;22(7):713-22.
Tanaka M, Nakayama J. Development of the gut microbiota in infancy and its impact on health in later life. Allergol Int. 2017;66(4):515-22.
Wopereis H, Oeze R, Belzer C, Knol J, Stahl B. The first thousand days - intestinal microbiology of early life: establishing a symbiosis. Pediatr Allergy Immunol. 2014;25(5):428-38.
Renz H, Skevaki C. Early life microbial exposures and allergy development. Curr Opin Allergy Clin Immunol. 2021;21(2):142-8.
Loo EX, Llanora GV, Lu Q, Aw MM, Lee BW, Shek LP. Probiotics for the prevention of atopic dermatitis in infants from high-risk families: a randomized controlled trial. J Allergy Clin Immunol Pract. 2019;7(5):1620-6.
Goldenberg JZ, Yap C, Lytvyn L, Adams A, Innes A, Lucas K, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2015;2015(12):CD004827.
Hao Q, Dong BR, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015;2015(2):CD006895.
Urbańska O, Szajewska H. The efficacy of Lactobacillus reuteri DSM 17938 in infant colic: a systematic review of randomized controlled trials. Eur J Pediatr. 2014;173(8):993-8.
Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096-103.
Gomez de Agüero M, Ganal-Vonarburg SC, Fuhrer T, Rupp S, Uchimura Y, Li H, et al. The maternal microbiota drives early postnatal innate immune development. Science. 2016;351(6279):1296-302.
Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J, et al. The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol Mol Biol Rev. 2017;81(4):e00036-17.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Joba E. I. Imbaquingo, Luis A. R. Vásconez, Claudia J. F. Delgado, Eliana M. C. Peñafiel, Gina V. L. Sarango, Jaime M. C. Vicente

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.